ES2140652T3 - Uso de n-alquil-derivados de 1,5-didesoxi-1,5-imino-d-glucitol para el tratamiento de infecciones por el virus de la hepatitis b. - Google Patents
Uso de n-alquil-derivados de 1,5-didesoxi-1,5-imino-d-glucitol para el tratamiento de infecciones por el virus de la hepatitis b.Info
- Publication number
- ES2140652T3 ES2140652T3 ES95905416T ES95905416T ES2140652T3 ES 2140652 T3 ES2140652 T3 ES 2140652T3 ES 95905416 T ES95905416 T ES 95905416T ES 95905416 T ES95905416 T ES 95905416T ES 2140652 T3 ES2140652 T3 ES 2140652T3
- Authority
- ES
- Spain
- Prior art keywords
- glucitol
- hepatitis
- treatment
- alkyl
- virus infections
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
SE PRESENTA UN METODO PARA EL TRATAMIENTO DE LAS INFECCIONES POR EL VIRUS DE LA HEPATITIS B (HBV) QUE COMPRENDE LA ADMINISTRACION AL ANFITRION INFECTADO DE UN DERIVADO DE N-ALQUILO DE 1,5-DIDEOXI-1,5-AMINO-D-GLUCITOL EN EL CUAL EL GRUPO DE ALQUILO CONTIENE ENTRE 3 Y 6 ATOMOS DE CARBONO.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US18151994A | 1994-01-13 | 1994-01-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2140652T3 true ES2140652T3 (es) | 2000-03-01 |
Family
ID=22664619
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES95905416T Expired - Lifetime ES2140652T3 (es) | 1994-01-13 | 1994-12-23 | Uso de n-alquil-derivados de 1,5-didesoxi-1,5-imino-d-glucitol para el tratamiento de infecciones por el virus de la hepatitis b. |
Country Status (14)
Country | Link |
---|---|
US (1) | US6037351A (es) |
EP (1) | EP0739205B1 (es) |
JP (1) | JP3628021B2 (es) |
KR (1) | KR100348657B1 (es) |
CN (1) | CN1074921C (es) |
AT (1) | ATE186836T1 (es) |
AU (1) | AU1403795A (es) |
CA (1) | CA2181033C (es) |
DE (1) | DE69421828T2 (es) |
DK (1) | DK0739205T3 (es) |
ES (1) | ES2140652T3 (es) |
GR (1) | GR3032527T3 (es) |
PT (1) | PT739205E (es) |
WO (1) | WO1995019172A1 (es) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030100532A1 (en) * | 1997-02-14 | 2003-05-29 | Gary S. Jacob | Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy for treating hepatitis virus infections |
AU753336B2 (en) | 1997-11-10 | 2002-10-17 | G.D. Searle & Co. | Use of alkylated iminosugars to treat multidrug resistance |
US6689759B1 (en) | 1998-02-12 | 2004-02-10 | G. D. Searle & Co. | Methods of Treating hepatitis virus infections with N-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy |
EP1714676A3 (en) * | 1998-02-12 | 2006-11-15 | G.D. Searle LLC. | Use of N-substituted-1,5-dideoxy-1,5-imino-D-glucitol compounds for treating hepatitis virus infections |
WO1999040916A1 (en) * | 1998-02-12 | 1999-08-19 | G.D. Searle & Co. | Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds for treating hepatitis virus infections |
US6274597B1 (en) | 1998-06-01 | 2001-08-14 | Mount Sinai School Of Medicine Of New York University | Method of enhancing lysosomal α-Galactosidase A |
CA2362785A1 (en) * | 1999-02-12 | 2001-02-08 | G.D. Searle & Co. | Glucamine compounds for treating hepatitis virus infections |
EP1658846B1 (en) * | 1999-02-12 | 2008-07-30 | United Therapeutics Corporation | N-(8,8,8-trifluorooctyl)-1,5-dideoxy-1,5-imino-D-glucitol for treating hepatitis virus infections |
WO2000047198A2 (en) * | 1999-02-12 | 2000-08-17 | G.D. Searle & Co. | Use of substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds for treating hepatitis virus infections |
DE60037664T2 (de) | 1999-08-10 | 2008-12-24 | The Chancellor, Masters And Scholars Of The University Of Oxford | Langkettige n-alkyl verbindungen und deren oxa-derivate zur verwendung als anitvirale mittel |
CN1422156A (zh) * | 2000-02-14 | 2003-06-04 | 法马西亚公司 | N-取代的-1,5-二脱氧-1,5-亚氨基-d-葡萄糖醇化合物在治疗肝炎病毒感染中的用途 |
CA2576425A1 (en) * | 2004-08-13 | 2006-08-17 | Migenix Inc. | Compositions and methods for treating or preventing hepadnaviridae infection |
EP2023927B1 (en) | 2006-05-24 | 2015-02-25 | United Therapeutics Corporation | Deoxynojirimycin and d-arabinitol analogs and methods of using |
WO2008063727A2 (en) * | 2006-08-21 | 2008-05-29 | United Therapeutics Corporation | Combination therapy for treatment of viral infections |
US8097728B2 (en) | 2007-04-30 | 2012-01-17 | Philadelphia Health & Education Corporation | Iminosugar compounds with antiflavirus activity |
JP2013233113A (ja) * | 2012-05-09 | 2013-11-21 | Osaka Univ | 物理的負荷への耐性が向上した細胞の製造方法 |
RU2743694C1 (ru) * | 2019-12-04 | 2021-02-24 | Общество с ограниченной ответственностью "29 февраля" | Миглустат N-бутил-1,5-дидезокси-1,5-имино-D-глюцит |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1555654A (en) * | 1977-06-25 | 1979-11-14 | Exxon Research Engineering Co | Agricultural burner apparatus |
US4849430A (en) * | 1988-03-09 | 1989-07-18 | Monsanto Company | Method of inhibiting virus |
US4957926A (en) * | 1988-12-22 | 1990-09-18 | Monsanto Company | Method of treating herpesviruses |
US5030638A (en) * | 1990-02-26 | 1991-07-09 | G. D. Searle & Co. | Method of antiviral enhancement |
-
1994
- 1994-12-23 DE DE69421828T patent/DE69421828T2/de not_active Expired - Lifetime
- 1994-12-23 DK DK95905416T patent/DK0739205T3/da active
- 1994-12-23 CA CA002181033A patent/CA2181033C/en not_active Expired - Lifetime
- 1994-12-23 US US08/676,153 patent/US6037351A/en not_active Expired - Lifetime
- 1994-12-23 CN CN94195049A patent/CN1074921C/zh not_active Expired - Lifetime
- 1994-12-23 KR KR1019960703780A patent/KR100348657B1/ko not_active IP Right Cessation
- 1994-12-23 WO PCT/US1994/014548 patent/WO1995019172A1/en active IP Right Grant
- 1994-12-23 EP EP95905416A patent/EP0739205B1/en not_active Expired - Lifetime
- 1994-12-23 ES ES95905416T patent/ES2140652T3/es not_active Expired - Lifetime
- 1994-12-23 JP JP51902495A patent/JP3628021B2/ja not_active Expired - Fee Related
- 1994-12-23 PT PT95905416T patent/PT739205E/pt unknown
- 1994-12-23 AU AU14037/95A patent/AU1403795A/en not_active Abandoned
- 1994-12-23 AT AT95905416T patent/ATE186836T1/de active
-
2000
- 2000-01-31 GR GR20000400223T patent/GR3032527T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
KR100348657B1 (ko) | 2003-08-02 |
DE69421828D1 (de) | 1999-12-30 |
JP3628021B2 (ja) | 2005-03-09 |
US6037351A (en) | 2000-03-14 |
AU1403795A (en) | 1995-08-01 |
CN1149253A (zh) | 1997-05-07 |
EP0739205B1 (en) | 1999-11-24 |
EP0739205A1 (en) | 1996-10-30 |
GR3032527T3 (en) | 2000-05-31 |
DK0739205T3 (da) | 2000-05-01 |
JPH09508111A (ja) | 1997-08-19 |
WO1995019172A1 (en) | 1995-07-20 |
CA2181033C (en) | 2007-09-04 |
ATE186836T1 (de) | 1999-12-15 |
CN1074921C (zh) | 2001-11-21 |
DE69421828T2 (de) | 2000-04-20 |
CA2181033A1 (en) | 1995-07-20 |
PT739205E (pt) | 2000-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2140652T3 (es) | Uso de n-alquil-derivados de 1,5-didesoxi-1,5-imino-d-glucitol para el tratamiento de infecciones por el virus de la hepatitis b. | |
BR9106374A (pt) | Vacina oral e processo de extrair uma imunoresponsta em um mamifero | |
UY26724A1 (es) | Métodos y composiciones para tratar el virus de la hepatitis c | |
YU94802A (sh) | 3-prolekovi 2'-deoksi-beta-l-nukleozida | |
DE69735634D1 (de) | Substituierte cyclopentanderivate die als neuramidase-inhibitoren nuetzlich sind | |
DE60105424D1 (de) | Methoden zur behandlung von delta hepatitis virus infektionen mit beta-l-2' deoxy-nucleosiden | |
DE69534264D1 (de) | Facettenreiches verfahren zur unterdrückung der vermehrung latenter viren in menschen und tieren | |
KR910021375A (ko) | 4-(디-n-프로필)아미노-6-아미노카보닐-1,3,4,5-테트라하이드로벤즈[cd]인돌의 결정형 염 | |
DE69027472T2 (de) | Arylsubstituierte Rhodaninderivate | |
ATE339211T1 (de) | L-fmau zur behandlung von hepatitis-delta-virus- infizierung | |
DK1666057T3 (da) | Fremgangsmåde til fremstilling af en acellulær vaccine indeholdende Bordetella pertussis antigener | |
DE69902103D1 (de) | Behandlung von hepatitis b mit thymosin alpha 1 und lamivudin | |
PH31116A (en) | Methods for the treatment of infection caused by hepatitis B virus (hbv). | |
ATE122562T1 (de) | Derivate von penciclovir zur behandlung von hepatitis-b-infektionen. | |
ES2014042A6 (es) | Un procedimiento para la preparacion de una composicion de 1-(2'-desoxi -2' fluor -b- d- arabinofuranosil) -5-etiluracilo. | |
KR920002497A (ko) | 스테롤 화합물 | |
KR960021043A (ko) | 스코폴레틴을 포함하는 b형 간염 치료제 | |
RS53223B (en) | METHODS AND MIXTURES FOR TREATMENT OF VIRAL HEPATITIS C | |
CO5090912A1 (es) | COMBINACION NOVEDOSA DE VACUNAS COMPRENDIENDO UN POLISACARI- DO Vi Salmonella typhi PURIFICADA Y POR LO MENOS OTRO ANTIGE NO Y METODOS PARA HACER LAS VACUNAS | |
GT199000061A (es) | Derivados amino acidos | |
MXPA94003453A (es) | Metodo y composicion para el tratamiento de pacientes con hepatitis b que tienen descompensacion hepatica. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 739205 Country of ref document: ES |